Company Overview
- Headquarters
- One Kendall Square Building 1400W, Cambridge MA
- Website
- kanyos.com
- Phone
- (617) 674-9924
- Employees
- 16
- Founded in
- 2015
- Industry
- BioTech/Drugs
- NAICS Code
-
NAICS Code 32 CompaniesNAICS Code 325 CompaniesNAICS Code 3254 Companies
- SIC Code
-
SIC Code 28 CompaniesSIC Code 283 Companies
Financials & Stats
Revenue
$3B
Total Funding Amount
$16M
Who is Kanyos Bio
Kanyos Bio is a privately held company based in Cambridge, Massachusetts. The company employs 16 people and has generated $3.4 million in revenue. Kanyos Bio focuses on developing antigen-specific immune tolerance technology for the treatment of autoimmune diseases. Their primary targets are type-1 diabetes and celiac disease. The company leverages the immunotechnology expertise of its sister company, Anokion, and the clinical translation experience of Astellas Pharma, Inc. (“Astellas”). Kanyos Bio's technology originated at EPFL (Ecole Polytechnique Fédérale Lausanne) in Switzerland. For more information, visit kanyos.com.
Kanyos Bio Industry Tags
Kanyos Bio Tech Stack
Companies Similar to Kanyos Bio
Analyze industry trends and opportunities by examining competitors and companies comparable to Kanyos Bio, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 6 | Cincinnati, OH | 2018 | |
| 3M | 28 | 2005 | ||
| 3M | 63 | Cambridge, MA | 2001 | |
| 3M | 5 | Del Mar, CA | 2017 | |
| 3M | 42 | Westlake Village, CA | 2010 |